CervoMed Inc - CRVO Net Assets per Single Share

CervoMed Inc. (CRVO) - corporate logo

CervoMed Inc. generates revenue by developing neuroprotectors to combat Alzheimer's and dementia, as evidenced by the history of the stock's book value. The 1.68 metric determines this capital level. The company is developing a unique ecosystem of kinase inhibitors for neurologists. The market currently prices in the lack of profit while awaiting the start of the final stages of clinical trials for its lead drug candidate.

CervoMed, Inc. (CRVO) Equity per Share: for the period 02/21/2024 - 10/28/2026

cervomed.com - analytical breakdowns and key metrics (CRVO)

- price and consensus price forecast:
Stock Quotes CervoMed Inc|CRVO - Price Target Chart
- market capitalization data:
Market Value CervoMed Inc.|CRVO - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share CervoMed|CRVO - Accounting Capitalization|Market Capitalization to Book Value Ratio cervomed.com|CRVO - Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio CervoMed Inc.|CRVO - Long-Term Debt to Capital|Short-Term Debt to Equity CervoMed|CRVO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio CervoMed Inc.|CRVO - Long-Term Debt|Company Short-Term Debts CervoMed
Fundamental company valuation:CervoMed Inc, CRVO
Manufactured products of CervoMed

The metric is calculated as the ratio of total net assets minus all liabilities to the number of shares outstanding, reflecting the actual capital density per share. For the biotechnology sector, characterized by high cash burn and the risk of clinical trial failures for CervoMed Inc. (CRVO), the growth rate of the book value per share serves as a critical indicator of the fundamental base's preservation amid market volatility.

Competitors of CervoMed Inc. (CRVO)

BIIB - Accounting Value per Share|NBIX: Net Assets per Single Share|Net Assets per Single Share RGC|AXSM (axsome.com) - Net Asset Value per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|Trevi Corp (TRVI) - Net Asset Value per Share|Book Value per Share PRAX|Accounting Value per Share anavex.com|CeriBell - Book Value per Share|Net Asset Value per Share PRTA (Prothena Corporation)|Net Assets per Single Share Alector|ANNX - Accounting Value of a Share|OMER - Accounting Value per Share|NGNE: Net Assets per Single Share|Net Assets per Single Share ACIU|VYGR (Voyager Therapeutics Inc) - Net Asset Value per Share|Net Assets per Single Share NMRA|Accounting Value per Share Scilex Holding Company, Inc.|Tevogen Bio Holdings - Book Value per Share|Net Asset Value per Share alphacognition.com (ACOG)|CGTX - Book Value per Share|IKT - Equity per Share|Accounting Value per Share Cassava (SAVA)|ASRT - Accounting Value of a Share|coyatherapeutics.com - Book Value per Share|VTGN (Vistagen) - Net Assets per Share|Net Assets per Single Share Ovid Therapeutics Inc (OVID)|Equity per Share Acumen Pharmaceuticals Inc.|Book Value per Share ATHE (Alterity Therapeutics)|Accounting Value per Share clene.com CLNN|Accounting Value per Share PEPG|Net Assets per Share Jupiter Neurosciences, Inc. JUNS|RLMD: Book Value per Share|ANVS: Accounting Value per Share|Net Assets per Single Share gracetx.com GRCE|Accounting Value of a Share Firefly Neuro|Accounting Value per Share ANEW Medical|Net Assets per Single Share NRSN|Reviva Pharmaceuticals Holdings, Inc. - Net Assets per Single Share|Net Asset Value per Share MTVA (metaviatx.com)|NRXS - Net Assets per Single Share|Equity per Share Helius Medical Technologies, Inc. HSDT|PASG (Passage Bio Corp) - Book Value per Share|Neuphoria Therapeutics Inc. (NEUP) - Net Asset Value per Share|NERV: Accounting Value per Share|ATHA (Athira Pharma Inc) - Book Value per Share|ADXN - Net Assets per Single Share|Accounting Value of a Share ALZN|Cyclerion Therapeutics - Net Assets per Single Share|Net Asset Value per Share protagenic.com (PTIX)|Pasithea Therapeutics Corp. - Book Value per Share|Accounting Value per Share Cortigent Inc CRGT|ATXI (Avenue Therapeutics, Inc) - Book Value per Share|BCLI: Net Asset Value per Share|Net Assets per Single Share Cara Therapeutics, Inc. CARA|Accounting Value of a Share chromocell.com|Accounting Value per Share Eliem Therapeutics, Inc.|Net Assets per Single Share ITCI|Longboard Pharma - Net Assets per Single Share|Net Asset Value per Share MRNS (Marinus Pharma)|NKGen Biotech, Inc. - Net Assets per Single Share|Accounting Value per Share neurobopharma.com NRBO|SAGE (Sage Therapeutics) - Book Value per Share|SNPX - Net Asset Value per Share|Book Value per Share Trevena, Inc|Equity per Share Vigil Neuroscience, Inc.|WENA - Accounting Value per Share|Accounting Value of a Share cerevel.com